Actavis Italia S.p.A.

Ukraine

All drugs from this manufacturer

  • DOCETAXEL-VISTA

    The drug is used to treat breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, and squamous cell carcinoma of the head and neck.

    Dosage form: concentrate for infusion solution

    Active substance Dosage
    docetaxel 20 mg/ml

    ATC: L01CD02

  • The drug is used to treat a wide range of oncological diseases, including acute leukemia, lymphoma, malignant tumors in children, as well as solid tumors in adults (e.g., breast and lung cancer).

    Dosage form: concentrate for infusion solution

    Active substance Dosage
    doxorubicin 2 mg/ml

    ATC: L01DB01

  • The drug is used to treat a wide range of tumors, including breast, ovarian, stomach, lung, and colorectal cancer, as well as malignant lymphomas and leukemias. It is also used to treat superficial bladder cancer.

    Dosage form: solution for injection

    Active substance Dosage
    epirubicin 2 mg/ml

    ATC: L01DB03

  • The drug is used for the treatment of patients with advanced colorectal cancer. It may be used as monotherapy or in combination with other medicinal products (e.g., 5-fluorouracil, folinic acid, cetuximab, bevacizumab, or capecitabine).

    Dosage form: concentrate for infusion solution

    Active substance Dosage
    irinotecan 20 mg/ml

    ATC: L01CE02

  • The drug is used for the treatment of patients with metastatic colorectal cancer. It may be used both in combination with other drugs (e.g., 5-fluorouracil, folinic acid, bevacizumab, cetuximab, or capecitabine) and as monotherapy if previous treatment has been ineffective.

    Dosage form: concentrate for infusion solution

    Active substance Dosage
    irinotecan 20 mg/ml

    ATC: L01XX19

  • The drug is used to treat invasive candidiasis and esophageal candidiasis (if intravenous administration is required). It is also used for the prevention of infections caused by Candida fungi in patients undergoing stem cell transplantation or those at risk of developing neutropenia.

    Dosage form: powder for solution for infusion

    Active substance Dosage
    micafungin 50 mg

    ATC: J02AX05

  • The drug is used to treat invasive candidiasis and esophageal candidiasis (if intravenous administration is required). It is also used for the prevention of infections caused by Candida fungi in patients undergoing stem cell transplantation or those at risk of developing neutropenia.

    Dosage form: powder for solution for infusion

    Active substance Dosage
    micafungin 100 mg

    ATC: J02AX05

  • The drug is used to treat ovarian cancer, breast cancer, advanced non-small cell lung cancer, as well as Kaposi's sarcoma in patients with AIDS.

    Dosage form: concentrate for infusion solution

    Active substance Dosage
    paclitaxel 6 mg/ml

    ATC: L01CD01

  • The drug is used for the treatment of non-small cell lung cancer (stage 3 or 4), as well as for the therapy of metastatic breast cancer stage 3 or 4, if previous treatment with anthracyclines has been ineffective or if a relapse has occurred.

    Dosage form: concentrate for infusion solution

    Active substance Dosage
    vinorelbine 10 mg/ml

    ATC: L01CA04